Leaderboard

The code is P9044. It's about 25% more than frozen plasma from our supplier.

Based on on of this I would be inclined to believe she never had an allo anti-D. I am tempted to climb on my soap box and spout a heated diatribe on the prenatal practice but I think I'll skip that this time.

I work in a children's hospital and we do aliquots on 95% of our products. We either fold the 4x4 label at the bottom or we write the sticker around the other side of the aliquot bag. We primarily fold the label for the syringe units. I don't think the 4x2 label you are showing is in compliance with ICCBBA standards since it doesn't have a DIN and no Product code plus how would you differentiate the parts of the product (i.e. Aa, Ab, Ac, etc.) if you don't have the product code? Besides its cheaper to have one label stock.

We are a smaller Level 1 Trauma Center, 600 beds, 13,000 transfusions last year with1 Vision. We do not irradiate or wash blood. We are lucky in that all techs work only in Blood Bank (which includes the Coag lab). We like an 8 week training period.

Our typical training period in slightly larger hospital is about 3 months (twice as long as yours). Most of our trainees are recent graduates (MT).

We apply the 4x4 horizontally and wrap the bottom part of the sticker around to the other side of the aliquot.

At the recent AABB meeting San Antonio reported on their program with whole blood out on ambulances and helicopters. When the blood bags come in with the patient to their ED, they are sent to BB so they can be crossmatched after the fact. Here, we keep segments from the units that we provide to our medical transport partner so we can crossmatch those brought to our facility if serological XM is needed or if a reaction occurs. In TX they have two level 1 trauma centers and I think more than one supplier for the units so they have to try to solve it at the receiving site.

How do you know it was alloanti-D if it was not ruled out? If she had a history of alloanti-D why did she receive RhIg? Anti-D tends to stay around for quite a while, in my experience. Are you sure you weren't detecting residual RhIg initially? To do or not do elution - you should follow your policy.

I'm with David on this one. Doing both paper and computer entry just adds one more opportunity for mistakes. If you can't trust some one to put it in the computer correctly how can you trust them to write it down correctly! The key is the ability to enter the results as they see them and not have to walk over to a computer station to do it. Also, if you are entering from an instrument print out I highly suggest you get that instrument interfaced as quickly as possible. Again, you are entering results from paper and that should be avoided.

I have to ask, how many times when the DAT is negative and you can elute the antibody from the babies cells does the infant show symptoms of a significant case of HDN (old guy, old nomenclature) resulting in an exchange transfusion or even phototherapy? Seems to me you are doing an awful lot of work for little, if any, benefit. See Malcolm's technical discussion above.

Question. If the patient is registered, why can't you use the SoftBank emergency issue function prior to the Type and Screen being completed?

We supply blood to a helicopter service with a contract with our hospital system. We put Safe-T-Vue indicators on all of their units. They provide us a copy of their in-flight chart when they transfuse anyone not coming to our hospitals. If the patient doesn't come to us but has an account in our HIS, we create a bogus registration in our BBIS using a defined format account number. If they don't exist in our HIS, we create a complete registration manually in our BBIS using a defined format for MR# etc. Then we emergency issue the product in our BBIS and handle it just as we would those patients who expire before a specimen is drawn etc. We charge the helicopter service for the products which they include in their flat fee to the patient. We maintain the final disposition records for any lookbacks etc. If we got a market withdrawal or lookback, we would notify the helicopter company to follow up with the recipient. That duty is at least vaguely covered in our agreement with them, I believe. We tell the helicopter crew to return any unused products to us and not to leave them at the receiving hospital but this isn't perfect. We sometimes transfer products on paper to the receiving site if we can document handling sufficiently. It doesn't work easily if the receiving hospital doesn't use the same blood supplier.